Your browser doesn't support javascript.
loading
Platelet-Based Nanoparticles with Stimuli-Responsive for Anti-Tumor Therapy.
Yang, Linlan; Zhang, Kaijiong; Zheng, Dongming; Bai, Yuxin; Yue, Daifan; Wu, Lichun; Ling, Han; Ni, Sujiao; Zou, Haimin; Ye, Bo; Liu, Chang; Deng, Yao; Liu, Qiancheng; Li, Yan; Wang, Dongsheng.
Affiliation
  • Yang L; College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
  • Zhang K; Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, People's Republic of China.
  • Zheng D; College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
  • Bai Y; College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
  • Yue D; College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
  • Wu L; Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, People's Republic of China.
  • Ling H; Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, People's Republic of China.
  • Ni S; Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, People's Republic of China.
  • Zou H; Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, People's Republic of China.
  • Ye B; Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, People's Republic of China.
  • Liu C; Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, People's Republic of China.
  • Deng Y; Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, People's Republic of China.
  • Liu Q; Department of Clinical Laboratory of Mianyang People's Hospital, Mianyang, People's Republic of China.
  • Li Y; College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
  • Wang D; College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
Int J Nanomedicine ; 18: 6293-6309, 2023.
Article in En | MEDLINE | ID: mdl-37954456

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nanoparticles / Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Int J Nanomedicine Year: 2023 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nanoparticles / Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Int J Nanomedicine Year: 2023 Document type: Article Country of publication: